$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Guillain-Barré syndrome after exposure to influenza virus

The Lancet. Infectious diseases, v.10 no.9, 2010년, pp.643 - 651  

Lehmann, Helmar C (Department of Neurology, Heinrich-Heine-University, Dü) ,  Hartung, Hans-Peter (sseldorf, Germany) ,  Kieseier, Bernd C (Department of Neurology, Heinrich-Heine-University, Dü) ,  Hughes, Richard AC (sseldorf, Germany)

Abstract AI-Helper 아이콘AI-Helper

Summary Guillain-Barré syndrome (GBS) is an acute, acquired, monophasic autoimmune disorder of peripheral nerves that develops in susceptible individuals after infection and, in rare cases, after immunisation. Exposure to influenza via infection or vaccination has been associated with G...

참고문헌 (115)

  1. Lancet Black 374 2115 2009 10.1016/S0140-6736(09)61877-8 Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines 

  2. J Infect Dis Evans 200 321 2009 10.1086/603560 “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events 

  3. Lancet Nicholson 362 1733 2003 10.1016/S0140-6736(03)14854-4 Influenza 

  4. N Engl J Med Dawood 360 2605 2009 10.1056/NEJMoa0903810 Emergence of a novel swine-origin influenza A (H1N1) virus in humans 

  5. Am J Epidemiol Schonberger 110 105 1979 10.1093/oxfordjournals.aje.a112795 Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977 

  6. Expert Rev Vaccines Iskander 7 75 2008 10.1586/14760584.7.1.75 Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience 

  7. Am J Epidemiol Stowe 169 382 2009 10.1093/aje/kwn310 Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database 

  8. PLoS One Tam 2 e344 2007 10.1371/journal.pone.0000344 Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database 

  9. Lancet Neurol van Doorn 7 939 2008 10.1016/S1474-4422(08)70215-1 Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome 

  10. Lancet Hughes 366 1653 2005 10.1016/S0140-6736(05)67665-9 Guillain-Barré syndrome 

  11. Curr Opin Neurol Hartung 15 571 2002 10.1097/00019052-200210000-00008 Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome 

  12. Brain Ho 118 597 1995 10.1093/brain/118.3.597 Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies 

  13. JAMA Ramos-Alvarez 207 1481 1969 10.1001/jama.1969.03150210065008 Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome 

  14. Curr Opin Immunol Yuki 17 577 2005 10.1016/j.coi.2005.09.004 Carbohydrate mimicry: a new paradigm of autoimmune diseases 

  15. Ann Neurol Halstead 58 203 2005 10.1002/ana.20546 Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome 

  16. Curr Opin Neurol Overell 18 562 2005 10.1097/01.wco.0000173284.25581.2f Recent developments in Miller Fisher syndrome and related disorders 

  17. J Peripher Nerv Syst Willison 10 94 2005 10.1111/j.1085-9489.2005.0010202.x The immunobiology of Guillain-Barré syndromes 

  18. J Neurol Neurosurg Psychiatry O'Leary 61 649 1996 10.1136/jnnp.61.6.649 Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides 

  19. J Neurol Neurosurg Psychiatry Rees 64 74 1998 10.1136/jnnp.64.1.74 Epidemiological study of Guillain-Barré syndrome in south east England 

  20. J Infect Dis Hughes 176 suppl 2 S92 1997 10.1086/513793 Clinical and epidemiologic features of Guillain-Barré syndrome 

  21. Curr Opin Neurol Govoni 14 605 2001 10.1097/00019052-200110000-00009 Epidemiology of the Guillain-Barré syndrome 

  22. Eur J Neurol Cheng 7 11 2000 10.1046/j.1468-1331.2000.00006.x Incidence of Guillain-Barré syndrome in Sweden 1996 

  23. Acta Neurol Scand Sedano 89 287 1994 10.1111/j.1600-0404.1994.tb01682.x Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study 

  24. J Peripher Nerv Syst Lehmann 12 285 2007 10.1111/j.1529-8027.2007.00150.x Incidence of Guillain-Barré syndrome in Germany 

  25. N Engl J Med Rees 333 1374 1995 10.1056/NEJM199511233332102 Campylobacter jejuni infection and Guillain-Barré syndrome 

  26. Neurology Jacobs 51 1110 1998 10.1212/WNL.51.4.1110 The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study 

  27. Muscle Nerve Kieseier 30 131 2004 10.1002/mus.20076 Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system 

  28. Nat Clin Pract Neurol zu Horste 3 198 2007 10.1038/ncpneuro0452 From bench to bedside-experimental rationale for immune-specific therapies in the inflamed peripheral nerve 

  29. Lancet Infect Dis Yuki 1 29 2001 10.1016/S1473-3099(01)00019-6 Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes 

  30. Brain Griffin 118 577 1995 10.1093/brain/118.3.577 Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases 

  31. Medicine Asbury 4 173 1969 10.1097/00005792-196905000-00001 The inflammatory lesion in idiopathic polyneuritis 

  32. Ann Neurol Hall 31 441 1992 10.1002/ana.410310416 Motor nerve biopsy in severe Guillain-Barré syndrome 

  33. Neurology Massaro 51 394 1998 10.1212/WNL.51.2.394 Nerve biopsy in children with severe Guillain-Barré syndrome and inexcitable motor nerves 

  34. Ann Neurol Hafer-Macko 40 635 1996 10.1002/ana.410400414 Acute motor axonal neuropathy: an antibody-mediated attack on axolemma 

  35. Muscle Nerve Hartung 18 137 1995 10.1002/mus.880180202 Immunopathogenesis and treatment of the Guillain-Barré syndrome-Part I 

  36. J Neuroimmunol Hughes 100 74 1999 10.1016/S0165-5728(99)00195-2 Pathogenesis of Guillain-Barré syndrome 

  37. Ann Neurol Ho 45 168 1999 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome 

  38. Neurology Yuki 40 1900 1990 10.1212/WNL.40.12.1900 Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis 

  39. Muscle Nerve Yuki 15 899 1992 10.1002/mus.880150806 Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies 

  40. Muscle Nerve Yuki 16 642 1993 10.1002/mus.880160610 Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome 

  41. J Neurol Neurosurg Psychiatry Willison 56 20406 1993 10.1136/jnnp.56.2.204 Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside 

  42. J Neuroimmunol Lopez 128 69 2002 10.1016/S0165-5728(02)00139-X High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies 

  43. Brain Lopez 131 1926 2008 10.1093/brain/awn074 Structural requirements of anti-GD1a antibodies determine their target specificity 

  44. J Neurosci Lehmann 27 27 2007 10.1523/JNEUROSCI.4017-06.2007 Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model 

  45. Ann Neurol Sheikh 56 228 2004 10.1002/ana.20173 An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice 

  46. J Neurosci Goodfellow 25 1620 2005 10.1523/JNEUROSCI.4279-04.2005 Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy 

  47. J Neurosci Susuki 27 3956 2007 10.1523/JNEUROSCI.4401-06.2007 Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers 

  48. Ann Neurol Yuki 49 712 2001 10.1002/ana.1012 Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside 

  49. Proc Natl Acad Sci USA Yuki 101 11404 2004 10.1073/pnas.0402391101 Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome 

  50. Muscle Nerve Arasaki 16 587 1993 10.1002/mus.880160603 Acute conduction block in vitro following exposure to antiganglioside sera 

  51. J Neurol Sci Arasaki 161 163 1998 10.1016/S0022-510X(98)00283-4 The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro 

  52. Neurosci Lett Buchwald 201 163 1995 10.1016/0304-3940(95)12155-2 Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice 

  53. Ann Neurol Buchwald 44 913 1998 10.1002/ana.410440610 Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study 

  54. Eur J Neurosci Buchwald 10 281 1998 10.1046/j.1460-9568.1998.00053.x Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals 

  55. Brain Halstead 127 2109 2004 10.1093/brain/awh231 Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy 

  56. Biomed Res Yuki 13 451 1992 10.2220/biomedres.13.451 Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between gangliocide GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni 

  57. Ann Neurol Yuki 36 791 1994 10.1002/ana.410360517 Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome 

  58. Eur J Biochem Aspinall 213 1017 1993 10.1111/j.1432-1033.1993.tb17849.x Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides 

  59. Infect Immun Aspinall 62 2122 1994 10.1128/IAI.62.5.2122-2125.1994 Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure 

  60. Infect Immun Neisser 65 4038 1997 10.1128/IAI.65.10.4038-4042.1997 Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome 

  61. Glycoconj J Hidari 24 583 2007 10.1007/s10719-007-9055-y Binding kinetics of influenza viruses to sialic acid-containing carbohydrates 

  62. N Engl J Med Moscona 353 1363 2005 10.1056/NEJMra050740 Neuraminidase inhibitors for influenza 

  63. Proc Am Philos Soc Taubenberger 150 86 2006 The origin and virulence of the 1918 “Spanish” influenza virus 

  64. Bull Hist Med Patterson 65 4 1991 The geography and mortality of the 1918 influenza pandemic 

  65. N Engl J Med Morens 361 225 2009 10.1056/NEJMp0904819 The persistent legacy of the 1918 influenza virus 

  66. Proc Natl Acad Sci USA Geiss 99 10736 2002 10.1073/pnas.112338099 Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza 

  67. Bull Mem Soc Med Hop Paris Guillain 40 1462 1916 Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux 

  68. Rev Neurol (Paris) Draganescu 2 517 1927 Sur un cas de radiculu-névrite curable (syndrome de Guillain-Barré) apparue au cours d'une ostéomyélite du bras 

  69. Can Med Assoc J Howland 9 727 1919 The nervous conditions associated with influenza 

  70. Proc R Soc Med Walshe 13 7 1920 Forms of peripheral neuritis among troops serving with the Egyptian expeditionary force, 1915-19 

  71. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr Marcus 54 166 1920 10.1007/BF02866117 Die Influenza und das Nervensystem. Studie während der Epidemie in Schweden 1918-1919 

  72. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr Wexberg 49 14 1919 10.1007/BF02901107 Erkrankungen der peripheren Nerven im Kriege 

  73. Eur Arch Psychiatry Clin Neurosci Sett 3 563 1920 Zur Ätiologie und Symptomatologie der Polyneuritis 

  74. Ir J Med Sci Keelan 438 272 1962 10.1007/BF02957017 Post-influenzal peripheral neuritis 

  75. AMA Arch Neurol Psychiatry Wells 81 699 1959 10.1001/archneurpsyc.1959.02340180033005 Guillain-Barré syndrome and virus of influenza A (Asian strain); report of two fatal cases during the 1957 epidemic in Wales 

  76. Clin Infect Dis Sivadon-Tardy 48 48 2009 10.1086/594124 Guillain-Barré syndrome and influenza virus infection 

  77. Emerg Infect Dis Sivadon-Tardy 12 990 2006 10.3201/eid1206.051369 Guillain-Barré syndrome, greater Paris area 

  78. Emerg Infect Dis Tam 12 1880 2006 10.3201/eid1212.051032 Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England 

  79. Arch Intern Med Zambon 161 2116 2001 10.1001/archinte.161.17.2116 Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza 

  80. N Engl J Med Falsey 352 1749 2005 10.1056/NEJMoa043951 Respiratory syncytial virus infection in elderly and high-risk adults 

  81. Intensive Care Med Chaari 36 1275 2010 10.1007/s00134-010-1895-4 Guillain-Barré syndrome related to pandemic influenza A (H1N1) infection 

  82. Neurocrit Care Kutleša 13 98 2010 10.1007/s12028-010-9365-y Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection 

  83. Minerva Med Mule 47 450 1956 Two cases of polyradiculoneuritis caused by influenza virus B [Italian] 

  84. Presse Med Bertrand 79 2328 1971 Guillain-Barré polyradiculoneuritis and influenza virus [French] 

  85. Cesk Neurol Neurochir Novák 38 314 1975 Guillain-Barré syndrome as a sequela of influenza [Czech] 

  86. Ann Neurol Enders 34 136 1993 10.1002/ana.410340208 The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders 

  87. Neurochem Res Adelmann 17 887 1992 10.1007/BF00993264 Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein 

  88. J Infect Dis Nachamkin 198 226 2008 10.1086/589624 Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome 

  89. Eur J Neurol Simpson 16 e81 2009 10.1111/j.1468-1331.2009.02569.x Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection 

  90. Emerg Infect Dis Sencer 12 29 2006 10.3201/eid1201.051007 Reflections on the 1976 swine flu vaccination program 

  91. JAMA Haber 292 2478 2004 10.1001/jama.292.20.2478 Guillain-Barré syndrome following influenza vaccination 

  92. Am J Epidemiol Safranek 133 940 1991 10.1093/oxfordjournals.aje.a115973 Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group 

  93. JAMA Marks 243 2490 1980 10.1001/jama.1980.03300500016019 Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine 

  94. JAMA Kaplan 248 698 1982 10.1001/jama.1982.03330060038030 Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination 

  95. N Engl J Med Hurwitz 304 1557 1981 10.1056/NEJM198106253042601 Guillain-Barré syndrome and the 1978-1979 influenza vaccine 

  96. Vaccine Vellozzi 27 2114 2009 10.1016/j.vaccine.2009.01.125 Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring 

  97. Arch Intern Med Hughes 166 1301 2006 10.1001/archinte.166.12.1301 No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000 

  98. Arch Intern Med Juurlink 166 2217 2006 10.1001/archinte.166.20.2217 Guillain-Barré syndrome after influenza vaccination in adults: a population-based study 

  99. Am J Epidemiol Roscelli 133 952 1991 10.1093/oxfordjournals.aje.a115974 Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988 

  100. N Engl J Med Lasky 339 1797 1998 10.1056/NEJM199812173392501 The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines 

  101. Ann Neurol McFarlin 27 suppl S25 1990 10.1002/ana.410270708 Immunological parameters in Guillain-Barré syndrome 

  102. J Peripher Nerv Syst Kuitwaard 14 310 2009 10.1111/j.1529-8027.2009.00243.x Recurrences, vaccinations and long-term symptoms in GBS and CIDP 

  103. J Neurol Neurosurg Psychiatry Kuitwaard 80 56 2009 10.1136/jnnp.2008.156463 Recurrent Guillain-Barré syndrome 

  104. Neurology Seyal 28 725 1978 10.1212/WNL.28.7.725 Recurrent Guillain-Barré syndrome following influenza vaccine 

  105. J Neurol Neurosurg Psychiatry Pritchard 73 348 2002 10.1136/jnnp.73.3.348 Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation 

  106. Neurology Wijdicks 55 452 2000 10.1212/WNL.55.3.452 Influenza vaccine and the risk of relapse of Guillain-Barré syndrome 

  107. Arch Soc Esp Oftalmol Blanco-Marchite 83 433 2008 10.4321/S0365-66912008000700008 Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination [Spanish] 

  108. Liver Transpl Moon 12 1537 2006 10.1002/lt.20864 Guillain-Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506 

  109. Muscle Nerve Aggarwal 18 1199 1995 10.1002/mus.880181017 A reversible paralytic syndrome with anti-GD1b antibodies following influenza immunization 

  110. Infect Immun Bowes 70 5008 2002 10.1128/IAI.70.9.5008-5018.2002 Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome 

  111. Infect Immun Kendal 29 966 1980 10.1128/iai.29.3.966-971.1980 Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations 

  112. Vaccine Wood 21 1786 2003 10.1016/S0264-410X(03)00073-2 The influenza vaccine licensing process 

  113. Aleccia 

  114. Plater 

  115. MMWR Morb Mortal Wkly Rep 59 657 2010 Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine-United States, 2009-2010 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로